Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM
Circ Heart Fail. 2025 Dec 5:e013418. doi: 10.1161/CIRCHEARTFAILURE.125.013418. Online ahead of print. ABSTRACT BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an important cause of morbidity and mortality …